The Muscle Loss Problem Is Real
This isn't a theoretical concern. When you lose weight on any intervention — GLP-1s, bariatric surgery, dieting — some of that weight comes from lean mass (muscle, bone, connective tissue). With GLP-1 medications specifically, the ratio is concerning:
| Drug / Trial | Total Weight Loss | % from Lean Mass |
|---|---|---|
| Semaglutide 2.4mg (STEP 1) | 14.9% | ~39% |
| Tirzepatide (SURMOUNT) | 20.9% | 33–38% |
| Pemvidutide (MOMENTUM Phase 2) | — | 21.9% |
| Semaglutide + Bimagrumab (BELIEVE) | 22.1% | 7.2% |
For a man who loses 40 pounds on semaglutide, roughly 15 pounds of that could be muscle — an amount that meaningfully reduces strength, metabolic rate, and functional capacity. For men over 40, who are already losing muscle at 3–8% per decade from sarcopenia, this accelerates a process that directly affects quality of life.
The BELIEVE Trial Changed the Conversation
The BELIEVE Phase 2b trial (507 participants, published in JAMA 2025) tested bimagrumab — a monoclonal antibody that targets activin type II receptors, promoting muscle preservation and growth — combined with semaglutide 2.4mg. The combination achieved 22.1% total body weight loss, with an unprecedented 92.8% of that loss coming from fat mass.
For context: in the semaglutide-alone group, only 71.8% of weight loss came from fat. The combination dramatically shifted the composition of weight loss from "losing everything, including muscle" to "losing almost exclusively fat."
The problem: bimagrumab is an IV infusion administered every 12 weeks and isn't commercially available yet. It's a proof of concept, not something you can get from your telehealth provider. But it proves that the muscle loss problem is solvable — the question is what men can do right now while the pharmaceutical solutions work through development.
The Case for Creatine During GLP-1 Therapy
No published clinical trial has studied creatine supplementation specifically in patients taking GLP-1 medications. We need to be honest about that. But the mechanistic rationale for adding creatine during GLP-1 therapy is strong enough to merit serious consideration.
What creatine does that matters here
Increases intracellular water retention in muscle cells. This creates a hydration-driven anabolic signal that promotes protein synthesis. During a caloric deficit (which GLP-1s create through appetite suppression), this anti-catabolic effect is especially valuable.
Enhances high-intensity exercise capacity. Creatine phosphate is the primary energy substrate for short-duration, high-intensity efforts — exactly the type of resistance training recommended for muscle preservation during GLP-1 therapy. If you can lift heavier, you send a stronger muscle-preservation signal.
May directly support lean mass retention during caloric restriction. Multiple studies in non-GLP-1 populations have shown that creatine supplementation during caloric restriction preserves more lean mass than restriction alone, particularly when combined with resistance training.
Has a decades-long safety profile. Creatine monohydrate is the single most studied sports supplement in history. The International Society of Sports Nutrition has confirmed its safety for long-term use. There are no known interactions with GLP-1 receptor agonist medications.
The Practical Protocol
Based on current evidence from exercise physiology, nutrition research, and GLP-1 clinical data, here's a framework for men looking to preserve muscle during GLP-1 therapy:
1. Resistance training — the non-negotiable
This is the single most important intervention. Resistance training sends the direct biological signal that your body needs its muscle tissue. Without this signal, your body treats muscle as expendable during a caloric deficit. Train 3–4 days per week with progressive overload. Compound movements (squat, deadlift, bench, row, overhead press) are more efficient than isolation exercises for this purpose. If you're not currently lifting, start with a basic strength program — even bodyweight movements at home are better than nothing.
2. Protein — the minimum effective dose
Current guidelines for GLP-1 patients recommend 1.2–1.5 grams of protein per kilogram of ideal body weight daily. For a man targeting 185 lbs (84 kg), that's 100–126 grams of protein per day. This is challenging on GLP-1s because appetite suppression makes it hard to eat enough — which is exactly why protein needs to be prioritized at every meal. Protein shakes, Greek yogurt, and lean meat become strategic tools, not optional add-ons.
3. Creatine monohydrate — the supplemental support
5 grams of creatine monohydrate daily. No loading phase needed — the research shows that daily supplementation of 3–5 grams reaches saturation within 3–4 weeks. Take it at any time, with or without food. Creatine monohydrate (not HCl, not ethyl ester, not any of the fancy branded versions) remains the most studied and most effective form.
4. The rest of the stack — what actually matters
Beyond creatine, a few other supplements have evidence for lean mass preservation during caloric restriction: vitamin D (most men are deficient, and deficiency is associated with muscle loss), omega-3 fatty acids (anti-inflammatory, may support protein synthesis), and branched-chain amino acids or essential amino acids (though these matter less if protein intake is already adequate).
What We're Still Waiting For
The research pipeline is moving fast. The BICEP study (NCT07226947) at Massachusetts General Hospital is recruiting right now — it's testing whether smartwatch-based activity monitoring and exercise guidance can improve muscle mass outcomes in patients starting GLP-1 therapy. A separate 2-year clinical trial (NCT07091500) is specifically evaluating body composition and muscle function in response to GLP-1 therapy with and without exercise training.
What we really need — and what doesn't exist yet — is a randomized controlled trial specifically testing creatine + resistance training + GLP-1 vs. resistance training + GLP-1 alone. Given the safety profile of creatine and the plausible mechanism, this seems like low-hanging research fruit. Until that data exists, the recommendation to supplement creatine is based on extrapolation from resistance training populations, not direct GLP-1 evidence.
For men who are already training and supplementing creatine: keep doing it. There's no reason to stop when starting a GLP-1. For men starting GLP-1s who don't currently resistance train: this is the moment to start. The muscle you preserve now is dramatically easier to keep than muscle you try to rebuild later.
SHED
Comprehensive GLP-1 program with multiple medication formats. Starting at $297–$299/mo.
Care Bare Rx
Compounded GLP-1 with intake consultation. From $199/month.